Mahadevia Ankit
- SEC CIK
- 0001720974
No open-market purchases or sales filed in the past year.
Current role at each company
- SPRO Spero Therapeutics, Inc.Directoras of Sep 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mahadevia Ankit as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 (view filing) | Aug 28 | 6 daysLate | Mahadevia AnkitDirector | SSale | −6.57K | $1.97 | −$12.9K | −0.9%703.3K after | |
| Feb 5, 2025 (view filing) | Feb 5 | Same day | Mahadevia AnkitDirector | SSale | −69.2K | $0.78 | −$54.0K | −9.1%689.9K after | 2 lots |
| Aug 29, 2024 (view filing) | Aug 27 | 2 days | Mahadevia AnkitDirector | SSale | −5.91K | $1.35 | −$7.98K | −0.8%759.1K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Mahadevia AnkitDirector | SSale | −63.8K | $1.37 | −$87.4K | −7.9%745.0K after | |
| Aug 30, 2023 (view filing) | Aug 28 | 2 days | Mahadevia AnkitDirector | SSale | −9.04K | $1.26 | −$11.4K | −1.1%788.8K after | |
| Feb 6, 2023 (view filing) | Feb 3 | 3 days | Mahadevia AnkitCEO and President | SSale | −12.3K | $1.81 | −$22.2K | −1.5%797.8K after | |
| Dec 29, 2021 (view filing) | Dec 27 | 2 days | Mahadevia AnkitCEO and President | SSale | −8.00K | $14.58 | −$116.6K | −5.3%144.0K after |